Emerging role of microRNAs in diagnosis and treatment of various diseases including ovarian cancer

Journal of Ovarian Research

Volumn 2, Issue 1, 2009, Pages

  Shah, Parag P ^a   Hutchinson, Lauren E ^a   Kakar, Sham S ^a  

^a UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC METAL COMPLEX; DOCETAXEL; DOXORUBICIN; GEMCITABINE; MICRORNA; PACLITAXEL; SURVIVAL MOTOR NEURON PROTEIN;

BLADDER CANCER; BREAST CANCER; CANCER DIAGNOSIS; CANCER RESISTANCE; CANCER THERAPY; CARCINOGENESIS; CELL DIFFERENTIATION; CHRONIC LYMPHATIC LEUKEMIA; COLON CANCER; COLORECTAL CANCER; DIABETES MELLITUS; DOWN REGULATION; ENDOMETRIUM CANCER; GENE CONTROL; GENE EXPRESSION; GLIOBLASTOMA; HEAD AND NECK CANCER; HEART DISEASE; HUMAN; LIVER CELL CARCINOMA; LUNG CANCER; NEUROBLASTOMA; NONHUMAN; OVARY CANCER; PARKINSON DISEASE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; REVIEW; SPINAL MUSCULAR ATROPHY; THYROID CARCINOMA; UPREGULATION; UTERINE CERVIX CANCER;

EID: 77950854543     PISSN: None     EISSN: 17572215     Source Type: Journal    
DOI: 10.1186/1757-2215-2-11     Document Type: Review

References (68)

1. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. RC Lee RL Feinbaum V Ambros, Cell 1993 75 843 854 10.1016/0092-8674(93)90529-Y 8252621
2. Oncomirs -microRNAs with a role in cancer. A Esquela-Kerscher FJ Slack, Nat Rev Cancer 2006 6 4 259 269 10.1038/nrc1840 16557279
3. Identification of hundreds of conserved and nonconserved human microRNAs. I Bentwich A Avniel Y Karov R Aharonov S Gilad O Barad, Nat Genet 2005 37 766 770 10.1038/ng1590 15965474
4. MicroRNA signatures in human ovarian cancer. MV Iorio R Visone G Di Leva V Donati F Petrocca P Casalini C Taccioli S Volinia CG Liu H Alder GA Calin S Menard, Cancer Res 2007 67 8699 8707 10.1158/0008-5472.CAN-07-1936 17875710
5. MicroRNA functions: Multiple mechanisms for a tiny RNA? R Pillai, RNA Journal 2005 11 1753 1761 10.1261/rna.2248605 (Pubitemid 41720024)
6. The genetic epidemiology of neurodegenerative disease. L Bertram R Tanzi, J Clin Invest 2005 115 6 1449 1457 10.1172/JCI24761 15931380
7. A cell biological perspective on mitochondrial dysfunction in Parkinson disease and other neurodegenerative diseases. W Mandemakers VA Morais B De Strooper, J Cell Sci 2007 120 Pt 10 1707 1716 10.1242/jcs.03443 17502481
8. A MicroRNA feedback circuit in midbrain dopamine neurons. J Kim K Inoue J Ishii WB Vanti SV Voronov E Murchison G Hannon A Abeliovich, Science 2007 317 5842 1220 1224 10.1126/science.1140481 17761882
9. Cerebellar neurodegeneration in the absence of microRNAs. A Schaefer D O'Carroll CL Tan D Hillman M Sugimori R Llinas P Greengard, J Exp Med 2007 204 7 1553 1558 10.1084/jem.20070823 17606634
10. MicroRNA pathways modulate polyglutamine-induced neurodegeneration. J Bilen N Liu BG Burnett RN Pittman NM Bonini, Mol Cell 2006 24 1 157 163 10.1016/j.molcel.2006.07.030 17018300
11. Dicer is essential for mouse development. E Bernstein SY Kim MA Carmell EP Murchison H Alcorn MZ Li AA Mills SJ Elledge KV Anderson GJ Hannon, Nat Genet 2003 35 3 215 217 10.1038/ng1253 14528307
12. A pancreatic islet-specific microRNA regulates insulin secretion. MN Poy L Eliasson J Krutzfeldt S Kuwajima X Ma PE Macdonald S Pfeffer T Tuschl N Rajewsky P Rorsman M Stoffel, Nature 2004 432 226 230 10.1038/nature03076 15538371
13. Numerous microRNPs in neuronal cells containing novel MicroRNAs. J Dostie Z Mourelatos M Yang A Sharma G Dreyfuss, RNA 2003 9 2 180 186 10.1261/rna.2141503 12554860
14. A New Role for MicroRNA Pathways: Modulation of Degeneration Induced by Pathogenic Human Disease Proteins. J Bilen N Liu NM Bonini, Cell Cycle 2006 5 24 2835 2838 17172864
15. The genetic basis for cardiac remodeling. F Ahmad JG Seidman CE Seidman, Annu Rev Genomics Hum Genet 2005 6 185 216 10.1146/annurev.genom.6.080604.162132 16124859
16. MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy? Y Cheng, Am J Pathol 2007 170 1831 1840 10.2353/ajpath.2007.061170 17525252
17. Expression of microRNAs is dynamically regulated during Cardiomyocyte hypertrophy. M Tatsuguchi HY Seok TE Callis JM Thomson JF Chen M Newman M Rojas SM Hammond DZ Wang, J Mol Cell Cardiol 2007 42 6 1137 1141 10.1016/j.yjmcc.2007. 04.004 17498736
18. MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths. D Sayed S Rane J Lypowy M He IY Chen H Vashistha L Yan A Malhotra D Vatner M Abdellatif, Mol Biol Cell 2008 19 3272 3282 10.1091/mbc.E08-02-0159 18508928
19. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. E Van Rooij LB Sutherland N Liu AH Williams J McAnally RD Gerard JA Richardson EN Olson, Proc Natl Acad Sci USA 2006 103 48 18255 18260 10.1073/pnas.0608791103 17108080
20. Control of stress-dependent cardiac growth and gene expression by microRNA. E Van Rooij LB Sutherland X Qi JA Richardson J Hill EN Olson, Science 2007 316 575 579 10.1126/science.1139089 17379774
21. MicroRNA-133 controls cardiac hypertrophy. A Carè D Catalucci F Felicetti D Bonci A Addario P Gallo ML Bang P Segnalini Y Gu ND Dalton L Elia MV Latronico M Høydal C Autore MA Russo GW Dorn 2nd O Ellingsen P Ruiz-Lozano KL Peterson CM Croce C Peschle G Condorelli, Nat Med 2007 13 5 541 10.1038/nm1582 17479098
22. Progress in the treatment of type 2 diabetes: new pharmacologic approaches to improve glycemic control. A Cohen ES Horton, Curr Med Res Opin 2007 23 905 917 10.1185/030079907X182068 17407648
23. Characterization of pancreatic transcription factor Pdx-1 binding sites using promoter microarray and serial analysis of chromatin occupancy. DM Keller S McWeeney A Arsenlis J Drouin CV Wright H Wang CB Wollheim P White KH Kaestner RH Goodman, J Biol Chem 2007 282 32084 32092 10.1074/jbc.M700899200 17761679
24. Transcription factors direct the development and function of pancreatic beta cells. SK Chakrabarti RG Mirmira, Trends Endocrinol Metab 2003 14 78 84 10.1016/S1043-2760(02)00039-5 12591178
25. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. GA Calin, Proc Natl Acad Sci USA 2002 99 15524 15529 10.1073/pnas.242606799 12434020
26. A microRNA polycistron as a potential human oncogene. L He, Nature 2005 435 828 833 10.1038/nature03552 15944707
27. MicroRNA gene expression deregulation in human breast cancer. MV Iorio M Ferracin CG Liu A Veronese R Spizzo S Sabbioni A Magri P Musiani S Volinia I Nenci GA Calin P Querzzoli, Cancer Res 2005 65 7065 7070 10.1158/0008-5472.CAN- 05-1783 16103053
28. Reduced accumulation of specific microRNAs in colorectal neoplasia. MZ Michael SM O'Connor NG Van Holst Pellekaan GP Young RJ James, Mol Cancer Res 2003 1 882 891 14573789
29. MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. V Ambros, Cell 2003 113 673 676 10.1016/S0092-8674(03)00428-8 12809598
30. miR-15 and miR-16 induce apoptosis by targeting BCL2. A Cimmino GA Calin M Fabbri, Proc Natl Acad Sci USA 2005 102 13944 13949 10.1073/pnas.0506654102 16166262
31. Genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. PM Voorhoeve C le Sage M Schrier, Cell 2006 124 1169 1181 10.1016/j.cell.2006.02.037 16564011
32. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. J Takamizawa H Konishi K Yanagisawa, Cancer Res 2004 64 3753 3756 10.1158/0008-5472.CAN-04-0637 15172979
33. RAS is regulated by the let-7 microRNA family. SM Johnson H Grosshans J Shingara, Cell 2005 120 635 647 10.1016/j.cell.2005.01.014 15766527
34. MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth. J Schultz P Lorenz G Gross S Ibrahim M Kunz, Cell Res 2008 18 549 557 10.1038/cr.2008.45 18379589
35. The widespread impact of mammalian MicroRNAs on mRNA repression and evolution. KK Farh A Grimson C Jan BP Lewis WK Johnston LP Lim CB Burge DP Bartel, Science 2005 310 5755 1817 21 10.1126/science.1121158 16308420
36. A polycistronic microRNA cluster, miR-17-92, is over expressed in human lung cancers and enhances cell proliferation. Y Hayashita, Cancer Res 2005 65 9628 9632 10.1158/0008-5472.CAN-05-2352 16266980
37. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. TC Chang, Molecular Cell 2007 26 745 752 10.1016/j.molcel.2007.05.010 17540599
38. A microRNA expression signature of human solid tumors defines cancer gene targets. S Volinia GA Calin CG Liu S Ambs A Cimmino F Petrocca R Visone M Iorio C Roldo M Ferracin RL Prueitt N Yanaihara G Lanza A Scarpa A Vecchione M Negrini CC Harris CM Croce, Proc Natl Acad Sci USA 2006 103 7 2257 2261 10.1073/pnas.0510565103 16461460
39. MicroRNAs exhibit high frequency genomic alterations in human cancer. L Zhang, Proc Natl Acad Sci USA 2006 103 9136 9141 10.1073/pnas.0508889103 16754881
40. Pathology of ovarian carcinoma. JD Seidman RJ Kurman, Hematol Oncol Clin North Am 2003 17 909 925 10.1016/S0889-8588(03)00061-3 12959182
41. CA125 and transvaginal ultrasound monitoring in high-risk women cannot prevent the diagnosis of advanced ovarian cancer. RI Olivier MA Lubsen-Brandsma S Verhoef M van Beurden, Gynecol Oncol 2006 100 1 20 26 10.1016/j.ygyno.2005.08. 038 16188302
42. Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development. M Gironella M Seux MJ Xie C Cano R Tomasini J Gommeaux S Garcia J Nowak ML Yeung KT Jeang A Chaix L Fazli, Proc Natl Acad Sci USA 2007 104 16170 16175 10.1073/pnas. 0703942104 17911264
43. The detection of differentially expressed MicroRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. K Resnick, Gynecol Oncol 2009 112 55 59 10.1016/j.ygyno.2008.08.036 18954897
44. MicroRNA signatures of tumor-derived exosome as diagnostic biomarkers of ovarian cancer. D Taylor C Gercel-Taylor, Gynecol Oncol 2008 110 13 21 10.1016/j.ygyno.2008.04.033 18589210
45. MicroRNAs and their target messenger RNAs associated with ovarian cancer response to chemotherapy. T Boren Yin Xiong Ardeshir Hakam, Gynecol Oncol 2009 113 249 255 10.1016/j.ygyno.2009.01.014 19237188
46. Tumor microRNA expression patterns associated with resistance to platinum based chemotherapy and survival in ovarian cancer patients. R Eitan, Gynecol Oncol 2009 doi: 10.1016/j.ygyno.2009.04.024 19446316
47. Implications of micro-RNA profiling for cancer diagnosis. JM Cummins VE Velculescu, Oncogene 2006 25 6220 6227 10.1038/sj.onc.1209914 17028602
48. MicroRNAs 143 and 145 are possible common onco-microRNAs in human cancers. Y Akao Y Nakagawa T Naoe, Oncol Rep 2006 16 845 850 16969504
49. Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and nontumoral tissues. E Bandres E Cubedo X Agirre R Malumbres R Zarate N Ramirez A Abajo, Mol Cancer 2006 5 29 10.1186/1476-4598-5-29 16854228
50. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. N Yanaihara N Caplen E Bowman M Seike K Kumamoto M Yi RM Stephens A Okamoto J Yokota T Tanaka GA Calin CG Liu, Cancer Cell 2006 9 189 198 10.1016/j.ccr.2006.01.025 16530703
51. A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. GA Calin M Ferracin A Cimmino, N Engl J Med 2005 353 1793 801 10.1056/NEJMoa050995 16251535
52. The role of microRNA genes in papillary thyroid carcinoma. H He K Jazdzewski W Li S Liyanarachchi R Nagi S Volinia GA Calin, Proc Natl Acad Sci USA 2005 102 19075 19080 10.1073/pnas.0509603102 16365291
53. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. JA Chan AM Krichevsky KS Kosik, Cancer Res 2005 65 6029 6033 10.1158/0008-5472.CAN- 05-0137 16024602
54. Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. H Kutay S Bai J Datta T Motiwala I Pogribny W Frankel ST Jacob, J Cell Biochem 2006 99 671 678 10.1002/jcb.20982 16924677
55. Cyclin G1 is a target of miR-122a, microRNA frequently down-regulated in human hepatocellular carcinoma. L Gramantieri M Ferracin F Fornari A Veronese S Sabbioni CG Liu GA Calin, Cancer Res 2007 67 6092 6099 10.1158/0008-5472.CAN-06- 4607 17616664
56. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular carcinoma. F Meng R Henson H Wehbe-Janek K Ghoshal ST Jacob T Patel, Gastroenterology 2007 133 647 658 10.1053/j.gastro.2007.05.022 17681183
57. Association of microRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. J Jiang Y Gusev I Aderca TA Mettler DM Nagorney DJ Brackett LR Roberts, Clin Cancer Res 2008 14 419 427 10.1158/1078-0432.CCR-07-0523 18223217
58. Micro-RNA profiling in kidney and bladder cancers. F Gottardo CG Liu M Ferracin GA Calin M Fassan P Bassi C Sevignani D Byrne M Negrini F Pagano LG Gomella CM Croce, Urol Oncol 2007 25 387 392 17826655
59. MicroRNA expression profiles in head and neck cancer cell lines. N Tran T McLean X Zhang CJ Zhao JM Thomson C O'Brien B Rose, Biochem Biophys Res Commun 2007 358 12 17 10.1016/j.bbrc.2007.03.201 17475218
60. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. AM Cheng MW Byrom J Shelton LP Ford, Nucleic Acids Res 2005 33 1290 1297 10.1093/nar/gki200 15741182
61. Expression profiling identifies microRNA signature in pancreatic cancer. EJ Lee Y Gusev J Jiang GJ Nuovo MR Lerner WL Frankel DL Morgan RG Postier DJ Brackett TD Schmittgen, Int J Cancer 2007 120 1046 1054 10.1002/ijc.22394 17149698
62. Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia. V Fulci S Chiaretti M Goldoni G Azzalin N Carucci S Tavolaro L Castellano A Magrelli F Citarella M Messina R Maggio N Peragine, Blood 2007 109 4944 4951 10.1182/blood-2006-12-062398 17327404
63. MicroRNAs and their target messenger RNAs associated with endometrial carcinogenesis. T Boren Y Xiong A Hakam R Wenham S Apte Z Wei S Kamath DT Chen H Dressman JM Lancaster, Gynecol Oncol 2008 110 206 215 10.1016/j.ygyno.2008.03. 023 18499237
64. MYCN regulates oncogenic MicroRNAs in neuroblastoma. JH Schulte S Horn T Otto B Samans LC Heukamp UC Eilers M Krause K Astrahantseff L Klein-Hitpass R Buettner A Schramm H Christiansen, Int J Cancer 2008 122 699 704 10.1002/ijc.23153 17943719
65. Oncogenic potential of the miR-106-363 cluster and its implication in human T-cell leukemia. S Landais S Landry P Legault E Rassart, ancer Res 2007 67 5699 5707 10.1158/0008-5472.CAN-06-4478 (Pubitemid 46985002)
66. Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers over expressing miR-17-92. H Matsubara T Takeuchi E Nishikawa K Yanagisawa Y Hayashita H Ebi H Yamada M Suzuki M Nagino Y Nimura H Osada T Takahashi, Oncogene 2007 26 6099 6105 10.1038/sj.onc.1210425 17384677
67. miRNA expression profiles in chronic lymphocytic and acute lymphocytic leukemia. DL Zanette F Rivadavia GA Molfetta FG Barbuzano R Proto-Siqueira WA Silva Jr, Braz J Med Biol Res 2007 40 1435 1440 17934639
68. MicroRNA expression and identification of putative miRNA targets in ovarian cancer. N Dahiya CA Sherman-Baust TL Wang B Davidson IeM Shih Y Zhang W Wood 3rd KG Becker PJ Morin, PLoS One 2008 3 6 2436 10.1371/journal.pone.0002436 18560586